# Pneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia

> **NCT05145101** · — · UNKNOWN · sponsor: **Hannah Garcia Garrido** · enrollment: 150 (estimated)

## Conditions studied

- Pneumococcal Infections
- Chronic Lymphocytic Leukemia
- Vaccine-Preventable Diseases
- Invasive Pneumococcal Disease, Recurrent Isolated

## Interventions

- **BIOLOGICAL:** Prevnar13

## Key facts

- **NCT ID:** NCT05145101
- **Lead sponsor:** Hannah Garcia Garrido
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-07
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05145101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05145101, "Pneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05145101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*